Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
142.50
Ask:
145.00
Spread: 2.50 (1.754%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

14 Jan 2021 07:00

RNS Number : 6127L
Xaar PLC
14 January 2021
 

Xaar plc

 

Trading update 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology, today announces a trading update for the year ended 31 December 2020.

 

TRADING

 

The Board is pleased to announce that, with the on-going successful implementation of the new strategy, trading was in line with its expectations. Revenue for the year was approximately £48m and in line with that recorded in FY2019.

 

The Printhead business continues to perform well with continued success in winning new customers. The customer-centric approach and focus on markets in which we have a competitive advantage is driving new business wins and seeing customers continue to re-engage. Additionally, our ImagineX platform is being successfully rolled out with a targeted product roadmap and clear growth opportunities ahead.

 

Despite the impact by COVID-19, our Product Print Systems business (EPS) has made progress with the strategy of developing a modular approach to products and, following the successful implementation of operational changes, the business is well placed for the future.

 

We have made further progress with product development and testing in Xaar 3D, despite continued COVID-19 related delays, and we continue to work closely with Stratasys to optimise the approach to commercialisation of the product range. 

 

BALANCE SHEET AND LIQUIDITY

 

The Group retains a strong balance sheet and cash position. Cash and cash equivalents at 31 December 2020 were £20.2m. This was driven by positive operational cash generation in both Printhead and EPS, as well as maintaining a strong focus on cash and disciplined cost controls.

 

CURRENT TRADING AND OUTLOOK

 

Despite the most recent COVID-19 lockdown, with pro-active management, we have maintained operational performance. Whilst COVID-19 continues to represent a key risk the order book remains strong with a positive pipeline. We continue to rigorously review opportunities available in the market, remaining focused on our strategy, and are on-track to return to profitability and growth.

 

 

John Mills, Chief Executive Officer, commented:

 

"We are very pleased with performance for the year which is a testament to the efforts of the team in extraordinary circumstances. We are one year into delivering our strategy and it is clearly having a positive impact, notably as existing customers continue to engage, and we are winning new business. We remain excited by the future and will remain disciplined in delivering long-term sustainable growth."

 

Enquiries:

 

Xaar plc

 

Ian Tichias, Chief Finance Officer

& Company Secretary

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

 

Tulchan Communications

James Macey White

Giles Kernick

Tom Blundell

 

 

 

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXLFFFFLFBBV
Date   Source Headline
4th Jul 20143:06 pmRNSHolding(s) in Company
4th Jul 20143:01 pmRNSHolding(s) in Company
3rd Jul 20149:41 amRNSHolding(s) in Company
1st Jul 201410:38 amRNSTotal Voting Rights
1st Jul 201410:38 amRNSBlocklisting Interim Review
27th Jun 201411:31 amRNSHolding(s) in Company
25th Jun 20145:53 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSDirector/PDMR Shareholding
24th Jun 20145:05 pmRNSDirector/PDMR Shareholding
20th Jun 20144:13 pmRNSHolding(s) in Company
20th Jun 201410:36 amRNSHolding(s) in Company
20th Jun 201410:19 amRNSHolding(s) in Company
17th Jun 20147:00 amRNSTrading Update
13th Jun 20147:00 amRNSAppointment of Corporate Broker
2nd Jun 20144:00 pmRNSTotal Voting Rights
14th May 20146:10 pmRNSResult of AGM
13th May 20147:00 amRNSGrant of Options
12th May 20145:58 pmRNSDirector/PDMR Shareholding
1st May 201412:10 pmRNSTotal Voting Rights
30th Apr 201411:35 amRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSDirector/PDMR Shareholding
23rd Apr 201410:08 amRNSNotice of 2014 AGM & Annual Financial Report
22nd Apr 20144:31 pmRNSDirector/PDMR Shareholding
17th Apr 201412:39 pmRNSDirector/PDMR Shareholding - Replacement
17th Apr 201412:08 pmRNSDirector/PDMR Shareholding
17th Apr 201411:20 amRNSDirector/PDMR Shareholding
16th Apr 20147:00 amRNSXaar plc - Interim Management Statement
10th Apr 20145:40 pmRNSHolding(s) in Company
4th Apr 201411:31 amRNSDirector/PDMR Shareholding
4th Apr 20149:13 amRNSGrant of Options
1st Apr 20149:25 amRNSTotal Voting Rights
28th Mar 20147:02 amRNSDirector/PDMR Shareholding
19th Mar 20143:58 pmRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNS2013 Full Year Results
13th Mar 20147:00 amRNSXaar plc - XAAR LAUNCHES THE XAAR 1002
28th Feb 201411:57 amRNSTotal Voting Rights
7th Feb 201410:42 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSTrading Statement
7th Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 201411:26 amRNSTotal Voting Rights
23rd Dec 20131:47 pmRNSHolding(s) in Company
16th Dec 20133:48 pmRNSHolding(s) in Company
13th Dec 20134:34 pmRNSHolding(s) in Company
13th Dec 20139:23 amRNSHolding(s) in Company
4th Dec 20133:28 pmRNSHolding(s) in Company
4th Dec 20132:20 pmRNSHolding(s) in Company
2nd Dec 20137:00 amRNSDirector/PDMR Shareholding
31st Oct 20134:37 pmRNSTotal Voting Rights
28th Oct 20134:21 pmRNSHolding(s) in Company
17th Oct 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.